Lymph Node Status Did Not Significantly Improve the Predictability of Survival in Patients With Clinically Early-Stage Endometrial Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bae, Hyo Sook | - |
dc.contributor.author | Lee, Jong-Min | - |
dc.contributor.author | Lee, Jae-Kwan | - |
dc.contributor.author | Kim, Jae-Weon | - |
dc.contributor.author | Cho, Chi-Heum | - |
dc.contributor.author | Kim, Seok-Mo | - |
dc.contributor.author | Park, Sang-Yoon | - |
dc.contributor.author | Park, Chan-Yong | - |
dc.contributor.author | Kim, Ki-Tae | - |
dc.contributor.author | Kang, Sokbom | - |
dc.date.available | 2020-02-28T16:41:40Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-10 | - |
dc.identifier.issn | 1048-891X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12231 | - |
dc.description.abstract | Objective: The aim of this study was to determine whether knowledge of lymph node status improves survival prediction in clinically early-stage endometrial cancer. Methods: The records of 661 patients with apparently uterine-confined disease were reviewed. The performance in predicting overall survival and cause-specific survival was compared between a multivariate prognostic model with nodal status and a model without nodal status by calculating Harrell concordance index. Results: Among 661 patients with clinically early-stage endometrial cancer, the lymph node metastasis rate was 8.3% (55/661). Lymph node metastasis independently associated with cause-specific survival only when no stratification according to adjuvant treatment was applied (P = 0.035). After stratification according to adjuvant radiotherapy, lymph node status marginally associated with cause-specific survival (P = 0.073), whereas myometrial invasion retained its strong association with cause-specific survival (P < 0.001). However, there was no significant difference in the performance of the survival model using only uterine factors and the model using lymph node status and uterine factors (concordance index, 0.77 vs 0.77, respectively; P = 0.798). Conclusions: Knowledge of lymph node status did not significantly improve the performance of survival prediction in apparently uterine-confined endometrial cancer, although it was independently associated with survival. In the patients with clinically early-stage endometrial cancer, the accuracy of the prediction of survival was comparable between risk grouping without lymph node status and that including lymph node status. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - |
dc.subject | GYNECOLOGIC-ONCOLOGY-GROUP | - |
dc.subject | UTERINE RISK-FACTORS | - |
dc.subject | PHASE-III TRIAL | - |
dc.subject | INTERMEDIATE-RISK | - |
dc.subject | ADENOCARCINOMA | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | RADIOTHERAPY | - |
dc.subject | MULTICENTER | - |
dc.subject | METASTASIS | - |
dc.subject | CARCINOMA | - |
dc.title | Lymph Node Status Did Not Significantly Improve the Predictability of Survival in Patients With Clinically Early-Stage Endometrial Cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000343096700016 | - |
dc.identifier.doi | 10.1097/IGC.0000000000000237 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, v.24, no.8, pp.1449 - 1454 | - |
dc.identifier.scopusid | 2-s2.0-84925685064 | - |
dc.citation.endPage | 1454 | - |
dc.citation.startPage | 1449 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - |
dc.citation.volume | 24 | - |
dc.citation.number | 8 | - |
dc.contributor.affiliatedAuthor | Park, Chan-Yong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Endometrial cancer | - |
dc.subject.keywordAuthor | Lymph node metastasis | - |
dc.subject.keywordAuthor | Risk factor | - |
dc.subject.keywordAuthor | Survival | - |
dc.subject.keywordPlus | GYNECOLOGIC-ONCOLOGY-GROUP | - |
dc.subject.keywordPlus | UTERINE RISK-FACTORS | - |
dc.subject.keywordPlus | PHASE-III TRIAL | - |
dc.subject.keywordPlus | INTERMEDIATE-RISK | - |
dc.subject.keywordPlus | ADENOCARCINOMA | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | RADIOTHERAPY | - |
dc.subject.keywordPlus | MULTICENTER | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.